Lv1
50 积分 2024-10-31 加入
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
3天前
已完结
Structural analysis of the inhibition of APRIL by TACI and BCMA through molecular dynamics simulations
15天前
已完结
Analytical expressions for the homotropic binding of ligand to protein dimers and trimers
15天前
已完结
Polyvalent Interactions in Biological Systems: Implications for Design and Use of Multivalent Ligands and Inhibitors
15天前
已完结
Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery
17天前
已完结
Strategic Approaches to Optimizing Peptide ADME Properties
17天前
已完结
Adapting ADME and Pharmacokinetic Analysis to the Next Generation of Therapeutic Modalities
17天前
已完结
Peptide-based drug discovery: Current status and recent advances
17天前
已完结
Cyclic Peptide Therapeutic Agents Discovery: Computational and Artificial Intelligence-Driven Strategies
17天前
已完结
Development of cyclic peptides that can be administered orally to inhibit disease targets
17天前
已完结
皖公网安备34019202002308
